Deborah Meltzer

Associate Lawyer

Deborah joined MBM in September of 2016, as part of the administrative support team and thereafter transitioned to an articling student in July of 2017. She was called to the bar in June of 2018, after which she continued her work at MBM as an associate in the Litigation department.

As a Montreal native, she studied at McGill University where she earned both her B.Sc. and M.Sc. specializing in biochemistry and environmental toxicology. Deborah then went on to pursue her law degree in the UK, at the University of Leeds.

Deborah’s work at MBM is primarily focused on litigation. She has participated as an advocate in trademark, copyright and patent disputes. She has also partaken in other matters including governmental exemption applications as well as an array of solicitor-based work. 

Before pursuing a career in law, Deborah had ten years of international sales experience. She was not only globally ranked but avidly participated in client service development programs. In her spare time she enjoys listening to podcasts, designing and painting – she has even sold a few of her commissions! Deborah is an avid traveler and loves learning about art history, tasting new cuisines and embracing different cultures all over the world


  • Bachelor of Science in Biochemistry (B.Sc.) – McGill University
  • Master of Science in Biochemistry (M.Sc.) (Specializing in Environmental Toxicology) – McGill University
  • Bachelor of Law (LL.B.) – University of Leeds

cb photo 111 561d6b13433c5JONATHAN ROCH


Jonathan assists clients with their intellectual property rights including patents, trademarks, copyrights, industrial designs and trade secretsMBM read_more_btn

MBM logo

About MBM

 The process of invention is complete only with the IP protection provided in law. That's where MBM comes in. We match our clients' creative thinking with the creative protection needed to achieve their goals.Read More About MBM

Clarifications to the Data Protection Guidance Document

Health Canada recently announced that section 2.1 of its Guidance Document re: Data Protection has been amended to clarify that the prior approval of a medicinal ingredient in a drug for veterinary use will not preclude the granting of data protection for a drug for...Read More